11 results
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
delays in the delivery of raw materials and drug product. Temporary closure of facilities at which our clinical or preclinical trials are conducted … results or other reasons, fail to approve the raw materials, manufacturing processes or facilities of third-party manufacturers upon which we rely, find
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
the raw materials, manufacturing processes or facilities of third-party manufacturers upon which we rely, find deficiencies in the manufacturing
S-1/A
COYA
Coya Therapeutics Inc
5 Dec 22
IPO registration (amended)
8:16am
to conduct additional testing, preclinical studies or clinical trials due to negative or inconclusive results or other reasons, fail to approve the raw … materials, manufacturing processes or facilities of third-party manufacturers upon which we rely, find deficiencies in the manufacturing processes
S-1
7m5mzqqcz5ctcmjt
18 Nov 22
IPO registration
5:06pm
DRS/A
w1ywgdikvb5dnpvni5
28 Oct 22
Draft registration statement (amended)
12:00am
DRSLTR
8njnk 9cqlhk
7 Oct 22
Correspondence regarding draft registration statement
12:00am
DRS/A
xt218ck4lqjfyl
7 Oct 22
Draft registration statement (amended)
12:00am
UPLOAD
5ik4dr0
15 Sep 22
Letter from SEC
12:00am
DRS
w8cncjsf
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next